DrugPatentWatch Database Preview

NATPARA Drug Profile

« Back to Dashboard

Summary for Tradename: NATPARA

Patents:	960
Applicants:	1
BLAs:	1
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NATPARA

Pharmacology for NATPARA

Ingredient-type

Parathyroid Hormone

US Patents for NATPARA

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23		ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)		RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23		SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)		RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23		Novartis AG (Basel, CH)		RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23		ASCENDIS PHARMA A/S (Hellrup, DK)		RX	Orphan	search

International Patents for NATPARA

Country	Document Number	Estimated Expiration
Japan	H09506869
Russian Federation	2195282
Greece	3025054
European Patent Office	1578762

Supplementary Protection Certificates for NATPARA

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
300864	Netherlands		PRODUCT NAME: ETELCALCETIDE OF EEN ZOUT DAARVAN, MET INBEGRIP VAN ETELCALCETIDEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1142/001-012 20161115
2010/036	Ireland		PRODUCT NAME: DENOSUMAB (PROLIA ); NAT REGISTRATION NO/DATE: EU/1/10/618/001 20100526; FIRST REGISTRATION NO/DATE: EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 26/05/2010 IRELAND EU/1/10/618/001 26/05/2010 IRELAND EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 20100526
300210	Netherlands		PRODUCT NAME: PEGVISOMANT; NATIONAL REGISTRATION NO/DATE: EU/1/02/240/002 20021115; FIRST REGISTRATION: EU EU/1/02/240/001 20021115
1090038-9	Sweden		PERIOD OF VALIDITY (FROM - UNTIL): 20220626 - 20250527